アキュリスファーマ株式会社（英語名：Aculys Pharma, Inc.）は “Catalyst to Access”（革新的な医療への橋渡しを担う）という理念から創られたAculysを社名とする日本発のバイオベンチャー企業です。神経・精神疾患領域において革新的な医療手段への橋渡し役となり、患者さんとご家族、医療関係者、社会により良い医療を届けるため、欧米諸国から革新的で優れた医薬品を導入し、開発・販売を担いさらに疾患を取り巻く様々な課題に対するソリューションを提供します。
Beyond the development and commercialization of new medicines, Aculys is
committed to the patient experience including the awareness, screening, diagnosis,
treatment of disease and the resolution of surrounding social issues for patients and their
families confronted with neurological and psychiatric disease. The company looks to
form comprehensive solutions through cross-sectional partnerships using new
technologies to enhance the patient experience.
Company Details
- Employees
- 21
- Founded
- 2021
- Address
- ２－１４－４kita Aoyama, The Argyle Aoyama 6f,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.aculys.com
- HQ
- Minato-ku, 東京都
Aculys Pharma Questions
Aculys Pharma's website is http://www.aculys.com
Aculys Pharma's LinkedIn profile is https://jp.linkedin.com/company/aculys
Aculys Pharma has
21 employees.
View email and phone details for 21
employees at Aculys Pharma.
Aculys Pharma's industry is
Pharmaceutical Manufacturing
Aculys Pharma's top competitors are
Japan Pharma Inc.,
Phost'in Therapeutics,
Sanofi,
4th European Congress Of Neurology And Neuropsychiatry,
Jazz Pharmaceuticals,
Oceanus Bio,
Bristol Myers Squibb,
Scohia Pharma, Inc.,
Amicus Therapeutics,
Daiichi Sankyo.
Aculys Pharma's categories are Pharmaceutical Manufacturing
Aculys Pharma's founding year is 2021
